Lantheus Holdings (LNTH) Net Margin (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Net Margin came in at 31.38% in Q1 2026, up 1181.0% year-on-year from 2.45% in Q1 2025, and up 136.02% on a QoQ basis from 13.3% in Q4 2025.
Lantheus Holdings (LNTH) Net Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Net Margin data on file, last reported at 31.38% in Q1 2026.
- On a quarterly basis, Net Margin rose 1181.0% year-over-year to 31.38% in Q1 2026; TTM through Mar 2026 was 18.05%, a 150.0% increase from a year earlier, with the FY2025 full-year figure at 15.15%, down 522.0% from the prior year.
- Net Margin for Q1 2026 stood at 31.38%, up from 13.3% in the prior quarter.
- Over the last five years, Net Margin for LNTH reached as high as 675.76% in Q4 2023 and fell as low as 45.29% in Q4 2022.
- Historically, Net Margin has averaged 55.33% across 5 years, with a median of 20.57% in 2022.
- Across the five-year window, Net Margin jumped 72105 bps in 2023 and tumbled 67877 bps in 2024, its largest moves.
- Year by year, Net Margin stood at 45.29% in 2022, then jumped by 1592 bps to 675.76% in 2023, then plunged by 100 bps to 3.01% in 2024, then soared by 541 bps to 13.3% in 2025, then jumped by 136 bps to 31.38% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 31.38% in Q1 2026, 13.3% in Q4 2025, and 7.23% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 31.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.38% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 7.23% |
| Jun 30, 2025 | 20.83% |
| Mar 31, 2025 | 19.57% |
| Dec 31, 2024 | -3.01% |
| Sep 30, 2024 | 34.61% |
| Jun 30, 2024 | 15.75% |
| Mar 31, 2024 | 35.43% |
| Dec 31, 2023 | 675.76% |
| Sep 30, 2023 | 41.24% |
| Jun 30, 2023 | 29.26% |
| Mar 31, 2023 | -0.93% |
| Dec 31, 2022 | -45.29% |
| Sep 30, 2022 | 25.59% |
| Jun 30, 2022 | 19.25% |
| Mar 31, 2022 | 20.57% |
| Dec 31, 2021 | -31.04% |
| Sep 30, 2021 | -13.14% |
| Jun 30, 2021 | -26.38% |